Cargando…
Tuning Design Parameters of ICAM-1-Targeted 3DNA Nanocarriers to Optimize Pulmonary Targeting Depending on Drug Type
3DNA holds promise as a carrier for drugs that can be intercalated into its core or linked to surface arms. Coupling 3DNA to an antibody targeting intercellular adhesion molecule 1 (ICAM-1) results in high lung-specific biodistributions in vivo. While the role of individual parameters on ICAM-1 targ...
Autores principales: | Roki, Nikša, Solomon, Melani, Bowers, Jessica, Getts, Lori, Getts, Robert C., Muro, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316040/ https://www.ncbi.nlm.nih.gov/pubmed/35890393 http://dx.doi.org/10.3390/pharmaceutics14071496 |
Ejemplares similares
-
A method to improve quantitative radiotracing‐based analysis of the in vivo biodistribution of drug carriers
por: Roki, Nikša, et al.
Publicado: (2021) -
ICAM‐1‐targeted nanocarriers attenuate endothelial release of soluble ICAM‐1, an inflammatory regulator
por: Manthe, Rachel L., et al.
Publicado: (2017) -
Biodistribution and endocytosis of ICAM-1-targeting antibodies versus nanocarriers in the gastrointestinal tract in mice
por: Mane, Viraj, et al.
Publicado: (2012) -
B-Cell-Targeted 3DNA Nanotherapy Against Indoleamine 2,3-Dioxygenase 2 (IDO2) Ameliorates Autoimmune Arthritis in a Preclinical Model
por: Merlo, Lauren MF, et al.
Publicado: (2020) -
A Strategy for Selective Deletion of Autoimmunity-Related T Cells by pMHC-Targeted Delivery
por: Goldberg, Shalom D., et al.
Publicado: (2021)